MaxCyte (MXCT)
(Delayed Data from NSDQ)
$3.88 USD
-0.06 (-1.52%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $3.87 -0.01 (-0.26%) 4:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for MaxCyte, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 168 | 227 | 255 | 35 | 17 |
Receivables | 6 | 14 | 7 | 5 | 3 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 12 | 9 | 5 | 4 | 4 |
Other Current Assets | 4 | 3 | 3 | 1 | 1 |
Total Current Assets | 190 | 252 | 270 | 45 | 24 |
Net Property & Equipment | 24 | 24 | 8 | 5 | 3 |
Investments & Advances | 43 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 1 | 0 | 0 | 0 |
Total Assets | 268 | 287 | 284 | 52 | 30 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 2 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 11 | 8 | 7 | 5 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 7 | 7 | 5 | 3 |
Total Current Liabilities | 18 | 15 | 16 | 12 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 5 | 5 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 0 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 36 | 33 | 21 | 19 | 16 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 407 | 391 | 376 | 128 | 96 |
Retained Earnings | -176 | -138 | -114 | -95 | -83 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 232 | 254 | 263 | 33 | 14 |
Total Liabilities & Shareholder's Equity | 268 | 287 | 284 | 52 | 30 |
Total Common Equity | 232 | 254 | 263 | 33 | 14 |
Shares Outstanding | 103.90 | 102.80 | 100.80 | NA | NA |
Book Value Per Share | 2.23 | 2.47 | 2.61 | 0.00 | 0.00 |
Fiscal Year End for MaxCyte, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 168 | 190 | 216 | 225 |
Receivables | NA | 6 | 8 | 8 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 12 | 13 | 11 | 10 |
Other Current Assets | NA | 4 | 3 | 2 | 2 |
Total Current Assets | NA | 190 | 214 | 237 | 246 |
Net Property & Equipment | NA | 24 | 24 | 24 | 25 |
Investments & Advances | NA | 43 | 18 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 1 | 1 | 0 |
Total Assets | NA | 268 | 267 | 271 | 282 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 0 | 2 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 11 | 10 | 6 | 7 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 6 | 5 | 6 |
Total Current Liabilities | NA | 18 | 17 | 13 | 17 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 1 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 36 | 33 | 30 | 34 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 407 | 403 | 399 | 396 |
Retained Earnings | NA | -176 | -171 | -159 | -149 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 232 | 233 | 241 | 248 |
Total Liabilities & Shareholder's Equity | NA | 268 | 267 | 271 | 282 |
Total Common Equity | 0 | 232 | 233 | 241 | 248 |
Shares Outstanding | 104.40 | 103.90 | 103.50 | 103.10 | 102.80 |
Book Value Per Share | 0.00 | 2.23 | 2.25 | 2.34 | 2.41 |